GeneCoda® Executive Search

Executive Insights for Life Sciences Innovators

Science EN ↓ Epizody: 30

Executive Insights features conversations with visionary leaders shaping the future of biotech, pharma, medtech, diagnostics, and tools. Hear from CEOs, entrepreneurs, and investors about building companies, raising capital, and driving innovation. Whether you are growing a startup or scaling a global life sciences business, these candid discussions deliver the insights you need to succeed.

Určitě navštivte web podcastu a podpořte jeho tvůrce: www.genecoda.com

Autor

GeneCoda® Executive Search

Kategorie

Science

Web podcastu

www.genecoda.com

Nejnovější epizoda

31. říj 2026

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Nainstaluj zdarma Android téměř 10 mil. stažení · hodnocení 4,7+ iOS už brzy

Epizody

Ayla Annac | CEO & Co-Founder, InvivoSciences – Precision Medicine for Heart Failure and Cardiometabolic Diseases 08.09.2025 40:35

In this episode of Executive Insights for Life Sciences Innovators , we sit down with Ayla Annac, CEO and Co-Founder of InvivoSciences , a precision medicine company transforming the way therapies are discovered and developed for heart failure and cardiometabolic diseases. Ayla shares insights into InvivoSciences’ innovative platform, the promise of patient-specific models in drug discovery, and t...

Anna Kazanchyan, MD | CEO, Saghmos Therapeutics – Cardiovascular and Kidney Protection with ST-62516 08.09.2025 33:48

In this episode of Executive Insights for Life Sciences Innovators , we speak with Anna Kazanchyan, MD, CEO of Saghmos Therapeutics , about the company’s mission to revolutionize cardiovascular and kidney protection. We explore how their lead drug candidate, ST-62516, is designed to prevent Major Adverse Cardiac and Kidney Events (MACKE) in high-risk patients undergoing PCI. Dr. Kazanchyan discuss...

Charles Swindell | CEO, Glycotest – Advancing Glycoprotein Biomarkers for Liver Disease Detection 08.09.2025 28:43

In this episode of Executive Insights for Life Sciences Innovators , we speak with Charles Swindell, CEO of Glycotest , about the company’s proprietary technology that measures glycoprotein fucosylation for the detection of liver diseases. Charles shares insights on the science behind Glycotest’s platform, the challenges of bringing diagnostic innovation to market, and the future of precision live...

Rich Shea | CEO, Basking Biosciences – RNA Aptamers for Acute Thrombosis Treatment 08.09.2025 30:16

In this episode of Executive Insights for Life Sciences Innovators , we sit down with Rich Shea, CEO of Basking Biosciences , to discuss the company’s pioneering work with RNA aptamer technology for the treatment of acute thrombosis. Rich shares insights on Basking’s scientific journey, the challenges of advancing a novel therapeutic approach, and the opportunities ahead in cardiovascular care. Le...

Dr. Nathan Stasko | CEO, Vast Therapeutics – Nitric Oxide Innovation in Respiratory Health 08.09.2025 26:06

In this episode of Executive Insights for Life Sciences Innovators , we speak with Dr. Nathan Stasko, CEO of Vast Therapeutics , about the company’s journey with nitric oxide technology in respiratory therapeutics. Dr. Stasko shares the challenges of advancing novel drug delivery approaches, lessons learned in building a biotech startup, and his perspective on innovation in life sciences. Learn mo...